Do the numbers hold clues to what lies ahead for the stock? See MEI Pharma, Inc. (MEIP) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Based on 9 Wall Street analysts offering 12 month price targets for MEI Pharma in the last 3 months. On average, Wall Street analysts predict that MEI PHARMA 's share price could reach $2.83 by Mar 25, 2023. MEIP Stock Predictions, Articles, and Mei Pharma Inc News From InvestorPlace From the Web 27 Biotechnology Stocks to Sell Now By Portfolio Grader Nov 7, 2016 This week, 27 Biotechnology stocks are . MEI Pharma, Inc. (MEIP) delivered earnings and revenue surprises of 31.58% and 139.26%, respectively, for the quarter ended December 2021. MEI Pharma expands early-stage zandelisib trial in specific blood cancer cohorts SA News Mon, Jan. 04, 2021 1 Comment MEI Pharma EPS misses by $0.06, beats on revenue In the previous week, MEI Pharma had 1 more articles in the media than AC Immune. Its drug candidates include Pracinostat, an oral HDAC inhibitor . About MEI Pharma. web search. MEI PHARMA ALERT: Bragar Eagel & Squire, P.C. Estimates. About MEI Pharma. Based on 9 Wall Street analysts offering 12 month price targets for MEI Pharma in the last 3 months. See MEI Pharma, Inc. (MEIP) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. View MEI Pharma, Inc MEIP investment & stock information. More. MEI Pharma, Inc. (Nasdaq: MEIP) is a late-stage pharmaceutical company focused on developing potential new therapies for cancer. What is MEIP's Earnings Per Share (EPS) forecast for 2022-2024? Get the latest MEI Pharma, Inc MEIP detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. This suggests a possible upside of 710.9% from the stock's current price. Alliance Global Partners Thinks MEI Pharma's Stock is Going to Recover. web search. is Investigating MEI Pharma, Inc. on Behalf of MEI Stockholders and Encourages Investors to Contact the Firm BU 05/17 SAN DIEGO & TOKYO, June 04, 2022--MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a global specialty pharmaceutical company creating innovative medical solutions utilizing the latest biotechnology, today announced data from the ongoing Phase 2 TIDAL study evaluating the . San Diego - December 1, 2021 - MEI Pharma, Inc. (Nasdaq: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, announced today that it has priced the underwritten public offering of 17,500,000 shares of its common stock at $2.60 per share for total gross proceeds (before underwriting discount and commissions . The average MEI PHARMA stock price prediction forecasts a potential upside of 437.57% from the current MEIP share price of $0.53. MEI Pharma, Inc. (MEIP) delivered earnings and revenue surprises of -46.67% and 340.09%, respectively, for the quarter ended December 2020. On average, they expect MEI Pharma's share price to reach $5.13 in the next year. Stock Picks. What was the 52-week high for MEI Pharma stock? Barchart Opinions show traders what a variety of popular trading systems are suggesting in terms of going long or short the market. Alliance Global Partners analyst Matthew Cross maintained a Buy rating on MEI Pharma (MEIP - Research Report) today and set a price target of $9.00. While ratings are subjective and will change, the latest MEI Pharma ( MEIP) rating was a maintained with a price target of $11.00 to $4.00. What is MEIP's Earnings Per Share (EPS) forecast for 2022-2024? As of 2022 June 05, Sunday current price of MEIP stock is 0.527$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. MEI Pharma stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period. This company is expected to post quarterly loss of $0.19 per share in its upcoming report, which represents a year-over-year change of +13.6%. On average, analysts forecast that MEIP's EPS will be -$0.59 for 2022, with the . Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. . Q3 2021. MEI Pharma, Inc. (MEIP) Reports Q2 Loss, Tops Revenue Estimates. The average price target represents a 787.78% change from the last price of $0.56. MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a global specialty pharmaceutical company creating innovative medical solutions utilizing the latest biotechnology, today announced data from the ongoing Phase 2 TIDAL study evaluating the intermittent dosing of zandelisib, an . Past 12 Months 12 Months Forecast -$1 $3.25 $7.5 $11.75 $16 Aug 2021 Nov Complete MEI Pharma Inc. stock information by Barron's. View real-time MEIP stock price and news, along with industry-best analysis. The average twelve-month price prediction for MEI Pharma is $5.13 with a high price target of $20.00 and a low price target of $1.00. 52-Week Range $0.41 - $3.55 Dividend & Yield N/A (N/A) MEIP Stock Predictions, Articles, and Mei Pharma Inc News From InvestorPlace From the Web 27 Biotechnology Stocks to Sell Now By Portfolio. msn back to msn home money. Complete MEI Pharma Inc. stock information by Barron's. View real-time MEIP stock price and news, along with industry-best analysis. Sat, 04 Jun 2022 MEI Pharma (MEIP) Stock Price: Why It Increased . According to the issued ratings of 7 analysts in the last year, the consensus rating for MEI Pharma stock is Buy based on the current 3 hold ratings and 4 buy ratings for MEIP. . MEI Pharma's portfolio of drug candidates . The highest, average, and lowest price target of all analysts. The current price MEI Pharma ( MEIP) is trading at is . The low in the last 52 weeks of MEI Pharma stock was 0.41. Find real-time MEIP - MEI Pharma Inc stock quotes, company profile, news and forecasts from CNN Business. Revenues are expected to be $7.62 million, down 16.9%. MEI Pharma's portfolio of drug candidates contains multiple clinical-stage assets, including zandelisib, currently in ongoing clinical trials which may support marketing approvals with the U.S. Food . Future price of the stock is predicted at 0$ ( -100% ) after a year according to our prediction system. The average price target is $5.00 with a high forecast of $15.00 and a low forecast of $1.00. Actuals. AC Immune's average media sentiment score of 0.84 beat MEI Pharma's score of -0.42 indicating that AC Immune is being referred to more favorably in the media. Sector Health Care Industry Biotechnology Employees 76 Founded 2000 Address 11455 El Camino Real San. MEI Pharma, Inc. (MEIP) delivered earnings and revenue surprises of 31.58% and 139.26%, respectively, for the quarter ended December 2021. These predictions take several variables into account such as volume changes, price changes, market cycles, similar stocks. (Expected Surprise Prediction) looks to find companies that have recently seen . MarketBeat recorded 5 mentions for MEI Pharma and 4 mentions for AC Immune. A high-level overview of MEI Pharma, Inc. (MEIP) stock. Today's 52-Week Highs; Today's 52-Week Lows; Volume . According to the issued ratings of 7 analysts in the last year, the consensus rating for MEI Pharma stock is Buy based on the current 3 hold ratings and 4 buy ratings for MEIP. Get the latest MEI Pharma, Inc MEIP detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. The average twelve-month price prediction for MEI Pharma is $5.13 with a high price target of $20.00 and a low price target of $1.00. MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced the expansion of its management team with the addition of two . MEI Pharma, Inc. (Nasdaq: MEIP) is a late-stage pharmaceutical company focused on developing potential new therapies for cancer. Q4 2021. A development stage company, engaged in the clinical development of the anti-cancer drug phenoxodiol. Find real-time MEIP - MEI Pharma Inc stock quotes, company profile, news and forecasts from CNN Business. MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced the expansion of its management team with the addition of two . The Opinions takes up to 5 years' worth of historical data and runs these prices through thirteen different technical indicators. (NASDAQ: MEIP) MEI PHARMA's current Earnings Per Share (EPS) is -$0.41. Interactive Chart MEIP S&P 500 Index Compare MEIP Stock to Peers News & Analysis: MEI Pharma. After each calculation, the program assigns a buy, sell or hold value for each study . The 6 analysts offering price forecasts for MEI Pharma have a median target of 3.00, with a high estimate of 5.00 and a low estimate of 1.00. The company's shares closed last Thursday at $1.83, close to its 52-week low of $1.68. 6 Wall Street analysts have issued 12-month price targets for MEI Pharma's shares. The average price target represents a 787.78% change from the last price of $0.56. MEIP : 0.5566 (-6.03%) MEI Pharma Strengthens Clinical and Quality Expertise with New Key Executive Appointments Business Wire - Mon Feb 7, 7:00AM CST. MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. MEIP updated stock price target summary. Stock Price Prediction: Update at 5:00pm EST: If tomorrow: Open lower Open higher High: 0.56 - 0.57 0.57 - 0.57 Low: . MEI Pharma (NASDAQ: MEIP) was reported by BTIG on March 25, 2022.The analyst firm set a price target for $4.00 expecting MEIP to rise to within 12 months (a possible . MEI Pharma Inc. MEI Pharma, Inc. is a pharmaceutical company, which engages in the clinical development of therapies for cancer. A. . msn back to msn home money. Learn more on MEIP's analyst rating . Their forecasts range from $1.00 to $20.00. In-depth view of key statistics and finances for MEI PHARMA, INC. (MEIP) on MSN Money. Shares in MEI Pharma ( MEIP -3.51%) are tumbling 15.3% at 11:55 a.m. EDT on Thursday following news its collaboration partner, Helsinn Group, is discontinuing a phase 3 trial of pracinostat in. According to the current price, MEI Pharma is 132.93% away from the 52-week low. The latest price target for . This suggests a possible upside of 710.9% from the stock's current price. In depth view into MEI Pharma Issuance of Stock explanation, calculation, historical data and more Investors in MEI Pharma, Inc. (MEIP Quick Quote MEIP - Free Report) need to pay close attention to the stock based on moves in the options market lately.That is because the Jun 19, 2020 $5.00 Call . View analysts' price targets for MEI Pharma or view top-rated stocks among Wall Street analysts. MEIP Issuance of Stock as of today (June 05, 2022) is $52.26 Mil. About the MEI Pharma Inc stock forecast. MEI Pharma Inc. analyst ratings, historical stock prices, earnings estimates & actuals. Today's 52-Week Highs; Today's 52-Week Lows; Volume . Their forecasts range from $1.00 to $20.00. Real time MEI Pharma (MEIP) stock price quote, stock graph, news & analysis. MEI Pharma, Inc. (MEIP) Reports Q2 Loss, Tops Revenue Estimates. The average price target is $5.00 with a high forecast of $15.00 and a low forecast of $1.00. Quarterly Numbers. MEIP will report Q3 2022 earnings on 09/01/2022. The average MEI PHARMA stock price prediction forecasts a potential upside of 518.56% from the current MEIP share price of $0.46. . On average, they expect MEI Pharma's share price to reach $5.13 in the next year. What are analysts forecasts for MEI Pharma stock? MEIP : 0.5566 (-6.03%) MEI Pharma Strengthens Clinical and Quality Expertise with New Key Executive Appointments Business Wire - Mon Feb 7, 7:00AM CST. In-depth view of key statistics and finances for MEI PHARMA, INC. (MEIP) on MSN Money. MEI Pharma, Inc. was incorporated in 2000 and is headquartered in San Diego, California. Stock Picks. This means that if you invested $100 now, your current investment may be worth 0$ on 2023 June 05, Monday. The.